Walgreens Boots Alliance (WBA) Tops Q4 EPS by 3c, Offers FY23 Guidance

October 13, 2022 7:02 AM EDT

Walgreens Boots Alliance (NASDAQ: WBA) reported Q4 EPS of $0.80, $0.03 better than the analyst estimate of $0.77. Revenue for the quarter came in at $32.4 billion versus the consensus estimate of $32.07 billion.


Walgreens Boots Alliance sees FY2023 EPS of $4.45-$4.65, versus the consensus of $4.53.

  • Expecting fiscal year 2023 adjusted EPS of $4.45 to $4.65 as strong core business growth is more than offset by lapping fiscal year 2022 COVID-19 execution, and currency headwinds
  • Raising U.S. Healthcare fiscal 2025 sales target to $11 billion to $12 billion, with the segment expected to achieve positive adjusted EBITDA by fiscal year 2024
  • Increased visibility to the company's long-term growth algorithm, building to low-teens adjusted EPS growth in fiscal year 2025 and beyond

For earnings history and earnings-related data on Walgreens Boots Alliance (WBA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities